In Brief: Product liability reform
This article was originally published in The Gray Sheet
Executive Summary
Product liability reform: Meeting between the staffers of Sens. Slade Gorton (R-Wash.) and John Rockefeller (D-W.Va.) and the White House to discuss a compromise on product liability legislation is expected to take place the week of Nov. 3. Compromise language negotiated by Rockefeller with the White House in September ("The Gray Sheet" Sept. 29, In Brief) reportedly has not been accepted by Republicans. In an Oct. 29 letter to President Clinton, 13 consumer organizations claim the legislation agreed to by Rockefeller and the White House would "have a catastrophic impact on millions of Americans"...
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.